Abdullah Sultan

Abdullah Sultan is a Senior Scientist 2 at Adicet Bio, Inc., focusing on the discovery and development of iPSC-derived therapies for oncology and inflammatory diseases since January 2023. Prior to this role, Abdullah held positions as Scientist 2 at Mitsubishi Tanabe Pharma America, leading projects on iPSC-derived CAR-NK cell therapies and hematopoietic stem cell optimization. Experience includes vital research on neurodegenerative diseases at Sanford Burnham Prebys Medical Discovery Institute, exploring biomarkers and neurovascular defects, with a strong background in stem cell therapeutics and cellular mechanisms related to Alzheimer's and Parkinson's diseases. Abdullah earned a Ph.D. in Cellular and Molecular Biology from the Centre for Cellular and Molecular Biology, with early education in Biochemistry and Biotechnology at Aligarh University.